Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 5/2006

01-12-2006

Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Authors: Katsumichi Fujimaki, Takehiko Mori, Aiko Kida, Masatsugu Tanaka, Nobutaka Kawai, Takafumi Matsushima, Kenji Kishi, Shin Fujisawa, Tohru Sakura, Akira Yokota, Yoshinobu Kanda, Jun Taguchi, Hideki Akiyama, Heiwa Kanamori, Atsuo Maruta, Shinichiro Okamoto, Hisashi Sakamaki, The Kanto Study Group for Cell Therapy

Published in: International Journal of Hematology | Issue 5/2006

Login to get access
Metadata
Title
Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Authors
Katsumichi Fujimaki
Takehiko Mori
Aiko Kida
Masatsugu Tanaka
Nobutaka Kawai
Takafumi Matsushima
Kenji Kishi
Shin Fujisawa
Tohru Sakura
Akira Yokota
Yoshinobu Kanda
Jun Taguchi
Hideki Akiyama
Heiwa Kanamori
Atsuo Maruta
Shinichiro Okamoto
Hisashi Sakamaki
The Kanto Study Group for Cell Therapy
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 5/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.06072

Other articles of this Issue 5/2006

International Journal of Hematology 5/2006 Go to the issue

Case report

Pancreatic Hyperamylasemia and Hyperlipasemia in Association with Cytomegalovirus Infection Following Unrelated Cord Blood Transplantation for Acute Myelogenous Leukemia

OriginalPaper

Combined Use of Dendritic Cells Enhances Specific Antileukemia Immunity by Leukemia Cell-Derived Heat Shock Protein 70 in a Mouse Model with Minimal Residual Leukemia Cells

OriginalPaper

Plasminogen Activator Inhibitor 1 Promotes a Poor Prognosis in Sepsis-Induced Disseminated Intravascular Coagulation

In memoriam

A Tribute to Professor Jean Bernard

Letter to the editor

Different Kinetics of wt1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia

Case report

Acute Myelomonocytic Leukemia with Dysplastic Bone Marrow Eosinophils Showing t(5;17)(q13;q11) and a Secondary Chromosomal Aberration, inv(16)(p13q22)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits